Abstract:ABSTRACT Novel respiratory viruses can cause a pandemic and then evolve to coexist with humans. The Omicron strain of severe acute respiratory syndrome coronavirus 2 has spread worldwide since its emergence in late 2021, and its sub-lineages are now established in human society. Compared to previous strains, Omicron is markedly less invasive in the lungs and causes less severe disease. One reason for this is that humans are acquiring immunity through previous infection and vaccination, but the nature of the virus itself is also changing. Using our newly established low-volume inoculation system, which reflects natural human infection, we show that the Omicron strain spreads less efficiently into the lungs of hamsters compared with an earlier Wuhan strain. Furthermore, by characterizing chimeric viruses with the Omicron gene in the Wuhan strain genetic background and vice versa , we found that viral genes downstream of ORF3a, but not the S gene, were responsible for the limited spread of the Omicron strain in the lower airways of the virus-infected hamsters. Moreover, molecular evolutionary analysis of SARS-CoV-2 revealed a positive selection of genes downstream of ORF3a (M and E genes). Our findings provide insight into the adaptive evolution of the virus in humans during the pandemic convergence phase. IMPORTANCE The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant has spread worldwide since its emergence in late 2021, and its sub-lineages are established in human society. Compared to previous strains, the Omicron strain is less invasive in the lower respiratory tract, including the lungs, and causes less severe disease; however, the mechanistic basis for its restricted replication in the lower airways is poorly understood. In this study, using a newly established low-volume inoculation system that reflects natural human infection, we demonstrated that the Omicron strain spreads less efficiently into the lungs of hamsters compared with an earlier Wuhan strain and found that viral genes downstream of ORF3a are responsible for replication restriction in the lower respiratory tract of Omicron-infected hamsters. Furthermore, we detected a positive selection of genes downstream of ORF3a (especially the M and E genes) in SARS-CoV-2, suggesting that these genes may undergo adaptive changes in humans.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **Why is the transmission ability of the Omicron variant limited in the lower respiratory tract?** Specifically, by establishing a small - volume intranasal inoculation system that simulates natural human infection and using hamsters as an animal model, the researchers explored the reasons why the Omicron variant has a lower transmission efficiency in the lower respiratory tract compared with the early Wuhan strain. The study found that some genes in the Omicron variant (especially those downstream of ORF3a, such as the M and E genes) may play a key role in limiting its transmission in the lower respiratory tract. In addition, molecular evolutionary analysis shows that these genes have undergone positive selection in SARS - CoV - 2, indicating that they may have changed during the virus's adaptation to humans. ### Main research contents: 1. **Establishment of a low - volume SARS - CoV - 2 infection system**: The researchers developed a low - volume (3 µL) intranasal inoculation system to more realistically reflect the situation of natural human infection. By comparing the infection effects of the high - volume (30 µL) and low - volume inoculation systems, it was found that the low - volume system can better simulate the natural infection process. 2. **Transmission ability of the Omicron variant in the lower respiratory tract**: Using the low - volume infection system, the researchers found that the transmission efficiency of the Omicron variant in the lower respiratory tract of hamsters is significantly lower than that of the early Wuhan strain. Immunohistochemical analysis also confirmed that the replication ability of the Omicron variant in the lungs is weak. 3. **Gene mapping**: By constructing a series of chimeric viruses, the researchers found that the S protein of the Omicron variant is not the main reason for its limited transmission in the lower respiratory tract. Further research shows that the genes located downstream of ORF3a (such as the M and E genes) may be the key factors causing this phenomenon. 4. **Molecular evolutionary analysis**: Through molecular evolutionary analysis of SARS - CoV - 2, the researchers found that the M and E genes in the Omicron variant have undergone positive selection, indicating that these genes may play an important role in the virus's adaptation to humans. ### Research significance: This study provides important insights into the adaptive evolution of SARS - CoV - 2 in human society, especially the mechanism of how the virus changes from high pathogenicity to low pathogenicity during the pandemic convergence stage. The research results are helpful to explain why the Omicron variant has a weak transmission ability in the lower respiratory tract and provide a scientific basis for further virus research and epidemic prevention and control.

Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution

Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology

Determinants of SARS-CoV-2 Receptor Gene Expression in Upper and Lower Airways

Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2

Contrasting patterns in the early stage of SARS-CoV-2 evolution between humans and minks

Signatures of adaptive evolution during human to mink SARS CoV2 cross-species transmission inform estimates of the COVID19 pandemic timing

SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice

The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5

Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants

Intrahost evolution leading to distinct lineages in the upper and lower respiratory tracts during SARS-CoV-2 prolonged infection

Evolutionary Dynamics of the Severe Acute Respiratory Syndrome Coronavirus 2 Genomes

Structural evolution of SARS-CoV-2 omicron in human receptor recognition

Host Immune Response Driving SARS-CoV-2 Evolution

Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters

Genetic variation analyses indicate conserved SARS‐CoV‐2–host interaction and varied genetic adaptation in immune response factors in modern human evolution

Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses

Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species

Distinct evolutionary trajectories of SARS-CoV-2-interacting proteins in bats and primates identify important host determinants of COVID-19

SARS‐CoV‐2 evolves to reduce but not abolish neutralizing action

Evolution of enhanced innate immune evasion by SARS-CoV-2

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates